Eisai Enters Into Joint Research Agreement With The Broad Institute To Develop An Antimalarial Medicine
World Pharma Today | June 13, 2017
Eisai Co Ltd announced that it has entered into a new joint research agreement with the Broad Institute , a collaborative research institute which includes researchers from the Massachusetts Institute of Technology and Harvard University to develop a new antimalarial medicine based on antimalarial drug targets the team identified last year.